Welcome to the Heinrich Lab, Jason!

We have a new graduate student in the Heinrich Lab, so please join us in welcoming Jason Kent!  Jason is currently pursuing his PhD in Cell and Developmental Biology at OHSU. He has been a part of the Heinrich Lab since the spring of 2017. He graduated with a B.S in Biochemistry at California Polytechnic State University San Luis
Obispo in 2014. Jason is using a functional yeast model to study SDH deficiency in GIST. 

Congratulations, Lilli and Amber!

We are so proud to congratulate our graduate students, Dr. Lillian Klug and Dr. Amber Bannon, on their successful completion of PhD programs at OHSU!  Dr. Klug presented her dissertation, “LMTK3 is necessary for oncogenic signaling and survival in KIT-mutant GIST and melanoma,” on Friday, September 22nd, 2017, and obtained her doctorate from the OHSU Cancer Biology Program.  Dr. Bannon presented her dissertation, “Translating Genetic Data into Actionable Clinical Guidelines: SDHA Variants of Unknown Significance in GIST,” on Friday, September 29th, 2017, and obtained her doctorate from the OHSU Department of Cell and Developmental Biology.  We have watched these ladies grow so much over the years and their contributions to GIST research and future therapies are invaluable!

Thank you, GCRF!

Thank you so much to all of the participants who joined us for the 2017 GIST Education Conference and Luncheon.  The event was not only informative for patients and researchers, it was an excellent opportunity to connect with each other.   Additionally, we want to express our gratitude to the GCRF for their incredibly generous donation. With your amazing fundraising efforts, we are able to continue to work hard to find a cure for this devastating disease.

Please be sure to watch our special Lab Tour video and see below for links to the speakers’ presentations.

PowerPoint Presentations:

Dr. Christopher Corless – Welcome

Amanda Bryant – Nutrition for Patients with GIST

Tracy Walker – How to Find and Participate in a GIST Clinical Trial

Lilli Klug – Exploring New Therapeutic Targets in GIST

Amber Bannon – Understanding SDH Mutations in GIST

Dr. Michael Heinrich – GIST Treatment Update



February is National Cancer Prevention Month

To encourage cancer prevention awareness during National Cancer Prevention Month, here are a few informational links for our patients, families, and friends. Please join us in promoting cancer education and donating to cancer research so we can fight GIST and other cancers.

GIST Cancer Research Foundation

GIST Support International

American Institute for Cancer Research

American Association for Cancer Research

Mayo Clinic


2016 GCRF Conference and Luncheon


We would like to extend our sincere gratitude to everyone who participated in the 2016 Annual GCRF Conference and Luncheon. It was wonderful to see so many of you and we hope you found a sense of community, patient support and helpful information at this event.  Additionally, we want to thank the GCRF for their incredibly generous donation. With your amazing fundraising efforts, we are able to continue to work hard to find a cure for this devastating disease.

Please click on the following links to view the presentations from the Conference:
Video of Dr. Heinrich’s Research Presentation

PowerPoint Presentations:
Research Updates
Surgery Updates
How to Find and Participate in a GIST clinical trial
Nutrition for Patients with GIST


IMG_1686DSC_0218DSC_0224 DSC_0236 DSC_0257 DSC_0274

IMG_1024 20160510_094913IMG_1283
IMG_1456 IMG_1454IMG_1457 IMG_1444 IMG_1447 IMG_1450

Lilli Klug receives AACR 2016 Women in Cancer Scholar Award


We are proud to announce that our graduate student, Lilli Klug, will receive an American Association for Cancer Research 2016 Women in Cancer Scholar Award at this year’s conference in New Orleans.  Congratulations, Lilli!

Abstract 191: LMTK3 is a novel regulator of oncogenic KIT in KIT-mutant cancers
Poster Session: Kinases and Phosphatases – #16
Sunday, April 17, 1 – 5 p.m.



Lillian Rose Klug, BS

Graduate Student
Oregon Health & Science University
Portland, Oregon

The ultimate goal of my research is to identify novel targets that may lead to improved therapies for patients with imatinib-resistant KIT-mutant cancers. I find this translational potential of cancer biology research incredibly rewarding and intend to pursue this goal throughout my career.”